Showing results (1-10 of 242) with videos related to
Sort By:
Pageof 25
Seminars in Cancer Biology|December 1, 1992
Tyrosine kinase inhibitorsP Workman, V G Brunton, D J RobinsAnti-Cancer Drug Design|August 1, 1994
Synthesis and antiproliferative activity of tyrphostins containing heteroaromatic moietiesV G Brunton, M J Lear, D J Robins, et al.Anti-Cancer Drug Design|September 1, 1996
Synthesis and antiproliferative activity of tyrphostins containing quinoline moietiesV G Brunton, M J Lear, P McKeown, et al.British Journal of Cancer|May 1, 1993
In vitro antitumour activity of the novel imidazoisoquinoline SDZ 62-434V G Brunton, P WorkmanAnti-Cancer Drug Design|August 1, 1994
Alterations in EGF-dependent proliferative and phosphorylation events in squamous cell carcinoma cell lines by a tyrosine kinase inhibitorV G Brunton, S Carlin, P WorkmanBritish Journal of Cancer|December 1, 1996
In vivo pharmacology and anti-tumour evaluation of the tyrphostin tyrosine kinase inhibitor RG13022H L McLeod, V G Brunton, N Eckardt, et al.Anti-Cancer Drug Design|June 1, 1996
Synthesis and biological evaluation of a series of tyrphostins containing nitrothiophene moieties as possible epidermal growth factor receptor tyrosine kinase inhibitorsV G Brunton, L R Kelland, M J Lear, et al.Cancer Chemotherapy and Pharmacology|April 2, 1998
Geldanamycin-induced cytotoxicity in human colon-cancer cell lines: evidence against the involvement of c-Src or DT-diaphoraseV G Brunton, G Steele, A D Lewis, et al.Anti-Cancer Drug Design|September 1, 1996
Synthesis and anti-cancer activity of 2,6-disubstituted N-methylpiperidine derivatives and their N-oxidesN D Henderson, J A Plumb, D J Robins, et al.Cellular and Molecular Life Sciences : CMLS|November 13, 2008
Loss of FrmA leads to increased cell-cell adhesion and impaired multi-cellular development of Dictyostelium cellsH Patel, V G BruntonPageof 25